SEC Tracker
Get the app
VRTX · XBRL financial data

Vertex Pharmaceuticals financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (VRTX's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue from contracts with customers2,518*2,6912,6462,7722,912*2,7702,9653,0763,190*2,9873,3343,441
Cost of goods and services sold368*343372393423*363408415466*393489526
Selling, general and administrative369*343372372378*396425445487*494582844
Operating income (loss)989*1,140(3,515)1,1161,026*6301,1511,1861,206*1,1381,247713
Interest expense11*101083*3433*——36
Other income (expense)(10)*(31)(23)(17)(15)*(18)13(10)7*024(12)
Income tax expense (benefit)179*180202179224*84250216140*222292130
Net income (loss)969*1,100(3,594)1,045913*6461,0331,0831,191*1,0311,100654
Earnings per share, basic USD per share3.76*4.26(13.92)4.053.55*2.524.024.244.70*4.064.342.58
Earnings per share, diluted USD per share3.72*4.21(13.92)4.013.63*2.493.994.204.65*4.024.312.56
Weighted average shares, basic millions of shares258*258258258257*257257256254*254254254
Weighted average shares, diluted millions of shares261*261258261251*260259258256*256255255

Balance sheet

CSV

Fiscal quarters (VRTX's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents10,3699,1584,5805,2394,5704,6754,9724,9405,0855,4936,1444,979
Marketable securities8491,0131,2151,2851,5461,5271,4111,3471,5231,7541,7091,324
Marketable securities, non-current2,4984,3814,3934,7045,1085,1575,6465,7235,7125,7505,7893,518
Accounts receivable1,5631,7931,6561,7511,6091,8051,8941,9462,0531,9962,1342,311
Inventory7398139151,0801,2051,3601,4991,6271,6871,7671,7652,245
Prepaid and other current assets624511575449666643652709853721792827
Total current assets14,14413,2898,9429,8049,59610,00910,42810,57011,20111,73012,54411,686
Right-of-use asset2943135701,3961,3571,3391,3141,5921,5631,6851,6631,617
Goodwill1,0881,0881,0881,0881,0881,0881,0881,0881,0881,0881,0882,423
Total assets22,73023,91720,13222,24022,53322,88124,03724,86225,64326,48427,42332,736
Accounts payable365351328396413445442420462489430473
Accrued liabilities2,6552,7962,9403,2202,7892,9523,2713,6142,9712,9843,1793,235
Current portion of long-term debt————————0——1,000
Total current liabilities3,5473,7963,5473,9733,5653,7834,1384,4753,8613,8813,9385,000
Long-term debt————————0——3,497
Lease liability, non-current3493605871,5891,5441,5381,5271,8351,8471,9871,9781,982
Total liabilities5,1505,3715,3576,6096,1246,3846,8617,5446,9777,1237,17511,829
Retained earnings10,14211,2427,6488,6949,60710,25311,28612,36913,56014,59115,69116,345
Total stockholders' equity17,58018,54714,77515,63116,41016,49617,17517,31918,66619,36220,24820,907
Total liabilities and equity22,73023,91720,13222,24022,53322,88124,03724,86225,64326,48427,42332,736
Common shares outstanding (cover page) millions of shares258258258258257257256254254254253254

Cash flows

CSV

Fiscal quarters (VRTX's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)969*1,100(3,594)1,045913*6461,0331,0831,191*1,0311,100654
Stock-based compensation209*192154*185*168*166167*195*158*166170*174*
Depreciation and amortization59*54545347*48525456*565769
Net cash from operating activities235*1,307(3,754)*1,370*585*8191,073*1,241*498*1,4281,125*643*
Purchases of property and equipment58*6869*68*93*41146*102*149*133112*97*
Net cash from investing activities(887)*(2,136)(464)*(348)*(822)*(56)(485)*(117)*(288)*(432)(46)*(6,101)*
Share repurchases150*131320*308*418*426392*1,071*128*337470*127*
Net cash from financing activities(120)*(358)(359)*(388)*(391)*(680)(349)*(1,155)*(77)*(539)(427)*4,297*
Net change in cash(744)*(1,203)(4,578)*657*(676)*113297*(34)*140*417649*(1,166)*

Compare with peers

The peer list for this company is being put together from its industry's latest filings. Reload the page in a minute to see it.

Not investment advice. Not affiliated with the U.S. SEC.